Therapeutic targeting of macrophages in lupus nephritis

Discovery Medicine

Volumn 20, Issue 108, 2015, Pages 43-49

  Chalmers, Samantha A ^a   Chitu, Violeta ^a   Ramanujam, Meera ^b   Putterman, Chaim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; FRACTALKINE; GW 2580; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; PLX 3397; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; CHEMOKINE; CHEMOKINE RECEPTOR;

ARTICLE; DRUG EFFICACY; DRUG TARGETING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LUPUS NEPHRITIS; MOUSE; PATHOLOGY;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; HUMANS; LUPUS NEPHRITIS; MACROPHAGES; MICE; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 84940886543     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, Bottinger EP, Ivashkiv L, Kretzler M, Davidson A. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J Immunol 186(8):4994-5003, 2011.
2. Bethunaickan R, Sahu R, Davidson A. Analysis of renal mononuclear phagocytes in murine models of SLE, In: Autoimmunity. pp 207-232. (Ed. A Perl.) Humana Press, 2012.
3. Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. J Am Soc Nephrol 21(12):2028-2035, 2010.
4. Chalmers S, Doerner J, Wen J, Putterman C. Macrophage depletion attenuates skin and kidney disease in lupus mice (BA7P.143). J Immunol 194(1 Suppl):115-113, 2015a.
5. Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. J Autoimmun 57(0):42-52, 2015b.
6. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in wistar-kyoto (WKY) rats by vMIP-II. J Exp Med 188(1):193-198, 1998.
7. Chitu V, Nacu V, Charles JF, Henne WM, Mcmahon HT, Nandi S, Ketchum H, Harris R, Nakamura MC, Stanley ER. PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood 120(15):3126-3135, 2012.
8. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18(1):39-48, 2006.
9. Conway JG, Mcdonald B, Parham J, Keith B, Rusnak DW, Shaw E, Jansen M, Lin P, Payne A, Crosby RM, Johnson JH, Frick L, Lin M-HJ, Depee S, Tadepalli S, Votta B, James I, Fuller K, Chambers TJ, Kull FC, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A 102(44):16078-16083, 2005.
10. Cros J, Cagnard N, Woollard K, Patey N, Zhang S-Y, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais J-P, D'cruz D, Casanova J-L, Trouillet C, Geissmann F. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 Receptors. Immunity 33(3):375-386, 2010.
11. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 69(7):1189-1197, 2006.
12. Fu Y, Du Y, Mohan C. Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol 124(2):109-118, 2007.
13. Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Lab Invest 91(7):978-991, 2011.
14. Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J-I, Yoshie O, Nose M, Fujita S. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum 48(9):2555-2566, 2003.
15. Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery J-P, Bariety J. Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophages. Kidney Int 59(1):304-316, 2001.
16. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 181(9):5829-5835, 2008.
17. Hutcheson J, Vanarsa K, Bashmakov A, Grewal S, Sajitharan D, Chang BY, Buggy JJ, Zhou XJ, Du Y, Satterthwaite AB, Mohan C. Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus. Arthritis Res Ther 14(6):R243, 2012.
18. Ikezumi Y, Suzuki T, Hayafuji S, Okubo S, Nikolic-Paterson DJ, Kawachi H, Shimizu F, Uchiyama M. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol Dialysis Transpl 20(12):2704-2713, 2005.
19. Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 52(5):1522-1533, 2005.
20. Iwata Y, Boström EA, Menke J, Rabacal WA, Morel L, Wada T, Kelley VR. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice. J Immunol, 2012.
21. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK, Pritchard S, Wodicka LM, et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26(1):127-132, 2008.
22. Kulkarni O, Eulberg D, Selve N, Zollner S, Allam R, Pawar RD, Pfeiffer S, Segerer S, Klussmann S, Anders HJ. Anti-Cc12 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J Pharmacol Exp Ther 328(2):371-377, 2009.
23. Lenda DM, Kikawada E, Stanley ER, Kelley VR. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170(6):3254-3262, 2003.
24. Lenda DM, Stanley ER, Kelley VR. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Faslpr mice. J Immunol 173(7):4744-4754, 2004.
25. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports 6:13, 2014.
26. Mcintosh LM, Barnes JL, Barnes VL, Mcdonald JR. Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis. Clin Exp Immunol 155(2):295-303, 2009.
27. Menke J, Amann K, Cavagna L, Blettner M, Weinmann A, Schwarting A, Kelley VR. Colony-stimulating factor-1: a potential biomarker for lupus nephritis. J Am Soc Nephrol 26(2):379-389, 2015.
28. Menke J, Iwata Y, Rabacal WA, Basu R, Stanley ER, Kelley VR. Distinct roles of CSF-1 isoforms in lupus nephritis. J Am Soc Nephrol 22(10):1821-1833, 2011.
29. Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J Am Soc Nephrol 20(12):2581-2592, 2009.
30. Mina-Osorio P, Lastant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, Demartino J, Narula S, et al. Suppression of glomerulonephritis in lupus-prone NZB x NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase. Arthritis Rheum 65(9):2380-2391, 2013.
31. Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 11(6):329-341, 2015.
32. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958-969, 2008.
33. Murray Peterj, Allen Judithe, Biswas Subhrak, Fisher Edwarda, Gilroy Derekw, Goerdt S, Gordon S, Hamilton Johna, Ivashkiv Lionelb, Lawrence T, Locati M, Mantovani A, Martinez Fernandoo, Mege J-L, Mosser Davidm, Natoli G, Saeij Jeroenp, Schultze Joachiml, Shirey Karia, Sica A, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41(1):14-20, 2014.
34. Nakatani K, Yoshimoto S, Iwano M, Asai O, Samejima K, Sakan H, Terada M, Hasegawa H, Nose M, Saito Y. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models. Am J Physiol Renal Physiol 299(1):F207-216, 2010.
35. Nathan C, Ding A. Nonresolving Inflammation. Cell 140(6):871-882, 2010.
36. Ni Gabhann J, Hams E, Smith S, Wynne C, Byrne JC, Brennan K, Spence S, Kissenpfennig A, Johnston JA, Fallon PG, Jefferies CA. Btk regulates macrophage polarization in response to lipopolysaccharide. PLoS One 9(1):e85834, 2014.
37. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 73(6):804-809, 1995.
38. Orme J, Mohan C. Macrophage subpopulations in systemic lupus erythematosus. Discov Med 69:151-158, 2012.
39. Perez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlondorff D, Luckow B. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol 16(12):3592-3601, 2005.
40. Plexxikon. A phase 2 study of PLX3397 in patients with recurrent glioblastoma. ClinicalTrials.gov, 2015.
41. Rankin AL, Seth N, Keegan S, Andreyeva T, Cook TA, Edmonds J, Mathialagan N, Benson MJ, Syed J, Zhan Y, Benoit SE, Miyashiro JS, Wood N, Mohan S, Peeva E, Ramaiah SK, Messing D, Homer BL, Dunussi-Joannopoulos K, Nickerson-Nutter CL, et al. Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis. J Immunol 191(9):4540-4550, 2013.
42. Rosa RF, Takei K, Araújo NC, Loduca SMA, Szajubok JCM, Chahade WH. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in brazilian patients. J Rheumatol 39(10):1948-1954, 2012.
43. Sahu R, Bethunaickan R, Singh S, Davidson A. Structure and function of renal macrophages and dendritic cells from lupus-prone mice. Arthritis Rheum 66(6):1596-1607, 2014.
44. Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MM, Bottinger EP, Davidson A. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 180(3):1938-1947, 2008.
45. Schulz C, Perdiguero EG, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SEW, Pollard JW, Frampton J, Liu KJ, Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336(6077):86-90, 2012.
46. Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Rheumatology 43(9):1121-1128, 2004.
47. Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, Kjellen P, Lambris JD, Christensson B, Hammarstrom L, et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152(2):557-565, 1994.
48. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 190(12):1813-1824, 1999.
49. Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, Van Rooijen N, Davidson A, Ivashkiv LB. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A 107(7):3012-3017, 2010.
50. Wermeling F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, Izui S, Ravetch JV, Tryggvason K, Karlsson MCI. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J Exp Med 204(10):2259-2265, 2007.
51. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 496(7446):445-455, 2013.
52. Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, Lan HY. Local macrophage proliferation in human glomerulonephritis. Kidney Int 54(1):143-151, 1998.
53. Yona S, Kim K-W, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume Davida, Perlman H, Malissen B, Zelzer E, Jung S. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38(1):79-91, 2013.
54. Yoshimoto S, Nakatani K, Iwano M, Asai O, Samejima K-I, Sakan H, Terada M, Harada K, Akai Y, Shiiki H, Nose M, Saito Y. elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis 50(1):47-58, 2007.
55. Yui MA, Brissette WH, Brennan DC, Wuthrich RP, Rubin-Kelley VE. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Pathol 139(2):255-261, 1991.
56. Zhang W, Xu W, Xiong S. Blockade of notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184(11):6465-6478, 2010.
57. Zhao W, Thacker SG, Hodgin JB, Zhang H, Wang JH, Park JL, Randolph A, Somers EC, Pennathur S, Kretzler M, Brosius FC, Kaplan MJ. the peroxisome proliferator-activated receptor γ agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J Immunol 183(4):2729-2740, 2009.
58. Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient Clearance of Early Apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189(7):3508-3520, 2012.